Vassilia Garypidou

The Stat3/5 Signaling Biosignature in Hematopoietic Stem/Progenitor Cells Predicts Response and Outcome in Myelodysplastic Syndrome Patients Treated with Azacitidine

Paraskevi Miltiades, Eleftheria Lamprianidou, Theodoros P. Vassilakopoulos et al. · Clinical Cancer Research · 2015 · 18 citations · Full text

Medicine, Oncology, Pharmacology +16

Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine

Paraskevi Miltiades, Eleftheria Lamprianidou, T. P. Vassilakopoulos et al. · Blood Cancer Journal · 2014 · 15 citations · Full text

Medicine, Immunology, Oncology +4

Platelet Activation in Essential Hypertension During Exercise: Pre- and Post-Treatment Changes With an Angiotensin II Receptor Blocker

E. Gkaliagkousi, Eleni Gavriilaki, E. Yiannaki et al. · American Journal of Hypertension · 2013 · 15 citations · Full text

Medicine, Cardiology, Physiology +13